The possibility of using immunocompetent ICR mice and immunodeficient SCID mice as model animals for smallpox to assess antiviral drug efficacy was investigated. Clinical signs of the disease did not appear following intranasal (i.n.) challenge of mice with strain Ind-3a of variola virus (VARV), even when using the highest possible dose of the virus (5.2 log10 p.f.u.). The 50 % infective doses (ID50) of VARV, estimated by the virus presence or absence in the lungs 3 and 4 days post-infection, were 2.7 ± 0.4 log10 p.f.u. for ICR mice and 3.5 ± 0.7 log10 p.f.u. for SCID mice. After i.n. challenge of ICR and SCID mice with VARV 30 and 50 ID50, respectively, steady reproduction of the virus occurred only in the respiratory tract (lungs and nose). Pathological inflammatory destructive changes were revealed in the respiratory tract and the primary target cells for VARV (macrophages and epithelial cells) in mice, similar to those in humans and cynomolgus macaques. The use of mice to assess antiviral efficacies of NIOCH-14 and ST-246 demonstrated the compliance of results with those described in scientific literature, which opens up the prospect of their use as an animal model for smallpox to develop anti-smallpox drugs intended for humans.
AmericoJ.L.,
MossB.,
EarlP.L.2010; Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models. J Virol 84:8172–8180 [View Article][PubMed]
CannJ.A.,
JahrlingP.B.,
HensleyL.E.,
Wahl-JensenV.2013; Comparative pathology of smallpox and monkeypox in man and macaques. J Comp Pathol 148:6–21 [View Article][PubMed]
DrozdovS.G.,
GarinN.S.,
DzindoyanL.S.,
TarasenkoV.M.1987[Fundamentals of Safety Practices in Microbiological and Virological Laboratories] Moscow: Medicine (in Russian);
EarlP.L.,
AmericoJ.L.,
MossB.2015; Genetic studies of the susceptibility of classical and wild-derived inbred mouse strains to monkeypox virus. Virology 481:161–165 [View Article][PubMed]
HahonN.,
McGavranM.H.1961; Air-borne infectivity of the variola-vaccinia group of poxviruses for the cynomolgus monkey, Macaca irus
. J Infect Dis 109:294–298 [View Article][PubMed]
HugginsJ.,
GoffA.,
HensleyL.,
MuckerE.,
ShamblinJ.,
WlazlowskiC.,
JohnsonW.,
ChapmanJ.,
LarsenT.,
other authors.
2009; Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother 53:2620–2625 [View Article][PubMed]
JahrlingP.B.,
HensleyL.E.,
MartinezM.J.,
LeducJ.W.,
RubinsK.H.,
RelmanD.A.,
HugginsJ.W.2004; Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. Proc Natl Acad Sci U S A 101:15196–15200 [View Article][PubMed]
Jordan, R., Bailey, T. R., Rippin, S. R. (2005). Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases. Patent WO 2004/112718 A3; International Patent Classification C07D 209/56.
JordanR.,
GoffA.,
FrimmA.,
CorradoM.L.,
HensleyL.E.,
ByrdC.M.,
MuckerE.,
ShamblinJ.,
BolkenT.C.,
other authors.
2009; ST-246 antiviral efficacy in a nonhuman primate monkeypox model: determination of the minimal effective dose and human dose justification. Antimicrob Agents Chemother 53:1817–1822 [View Article][PubMed]
JordanR.,
LeedsJ.M.,
TyavanagimattS.,
HrubyD.E.2010; Development of ST-246 for treatment of poxvirus infections. Viruses 2:2409–2435 [View Article][PubMed]
KaptsovaT.I.1967The development of experimental models for smallpox PhD thesis, Mechnikov's Research Institute of Vaccines and Serums, Moscow (in Russian).
MurtiB.R.,
ShrivastavJ.B.1957; A study of biological behaviour of variola virus. II. Experimental inoculation of laboratory animals. Indian J Med Sci 11:580–587[PubMed]
NalcaA.,
HatkinJ.M.,
GarzaN.L.,
NicholsD.K.,
NorrisS.W.,
HrubyD.E.,
JordanR.2008; Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model. Antiviral Res 79:121–127 [View Article][PubMed]
NobleJ.Jr1970; A study of New and Old World monkeys to determine the likelihood of a simian reservoir of smallpox. Bull World Health Organ 42:509–514[PubMed]
SarkarJ.K.,
MitraA.C.,
MukherjeeM.K.,
DeS.K.,
MazumdarD.G.1973a; Virus excretion in smallpox. 1. Excretion in the throat, urine, and conjunctiva of patients. Bull World Health Organ 48:517–522[PubMed]
SarkarJ.K.,
MitraA.C.,
MukherjeeM.K.,
DeS.K.1973b; Virus excretion in smallpox. 2. Excretion in the throats of household contacts. Bull World Health Organ 48:523–527[PubMed]
SergeevA.A.,
KabanovA.S.,
BulychevL.E.,
PyankovO.V.,
BodnevS.A.,
GorbatovskayaD.O.,
ZamedyanskayaA.S.,
ShishkinaL.N.,
AgafonovA.P.,
SergeevA.N.2013; [The study of the sensitivities of animals and primary target cell cultures to particularly dangerous orthopoxiruses]. In Proceedings of the Scientific and Practical Conference “Diagnosis and Prevention of Infectious Diseases”, Novosibirsk pp. 23–25 Novosibirsk: Areal (in Russian)
SergeevA.A.,
KabanovA.S.,
BulychevL.E.,
SergeevA.A.,
PyankovO.V.,
BodnevS.A.,
GalahovaD.O.,
ZamedyanskayaA.S.,
TitovaK.A.,
other authors.
2015a; The possibility of using the ICR mouse as an animal model to assess antimonkeypox drug efficacy. Transbound Emerg Dis. [View Article]
SergeevA.A.,
KabanovA.S.,
BulychevL.E.,
SergeevA.A.,
PyankovO.V.,
BodnevS.A.,
GalahovaD.O.,
ZamedyanskayaA.S.,
TitovaK.A.,
other authors.
2015b; Using the ground squirrel (Marmota bobak) as an animal model to assess monkeypox drug efficacy. Transbound Emerg Dis. [View Article]
Shafrikova, R. A. (1970). [The properties of freshly isolated strains of variola virus and the study of the virus variability under natural and experimental conditions]. PhD thesis, Mechnikov's Research Institute of Vaccines and Serums, Moscow (in Russian)..
Shishkina, L. N., Sergeev, A. N., Agafonov, A. P., Sergeev, A. A., Kabanov, A. S., Bulychev, L. E., Sergeev, A. A., Gorbatovskaya, D. O., P'yankov, O. V. and other authors (2015). [A therapeutic and prophylactic drug against variola virus and methods for its preparation and use]. Patent RU no. 2543338, Bulletin no. 6, dated 02.27.15 (in Russian)..
SmithS.K.,
OlsonV.A.,
KaremK.L.,
JordanR.,
HrubyD.E.,
DamonI.K.2009; In vitro efficacy of ST246 against smallpox and monkeypox. Antimicrob Agents Chemother 53:1007–1012 [View Article][PubMed]
StabenowJ.,
BullerR.M.,
SchriewerJ.,
WestC.,
SagartzJ.E.,
ParkerS.2010; A mouse model of lethal infection for evaluating prophylactics and therapeutics against monkeypox virus. J Virol 84:3909–3920 [View Article][PubMed]
Wahl-JensenV.,
CannJ.A.,
RubinsK.H.,
HugginsJ.W.,
FisherR.W.,
JohnsonA.J.,
de Kok-MercadoF.,
LarsenT.,
RaymondJ.L.,
other authors.
2011; Progression of pathogenic events in cynomolgus macaques infected with variola virus. PLoS One 6:e24832 [View Article][PubMed]
ZamedyanskayaA.S.,
TitovaK.A.,
SergeevA.A.,
KabanovA.S.,
BulychevL.E.,
SergeevA.A.,
GalakhovaD.O.,
NesterovA.E.,
NosarevaO.V.,
other authors.
2014; Infectious properties of variola versus on primary human and mouse monocyte-macrophage cultures. In 1st International Conference of Young Scientists: Collected Abstracts of Novosibirsk State University pp. 64–67 Novosibirsk: RIC NSU (In Russian)